Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for ROSUVASTATIN

Ingredient

ROSUVASTATIN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TEVA-ROSUVASTATIN	10MG	TABLET	Resolved	2022-04-28	2022-05-06	159596
TEVA-ROSUVASTATIN	10MG	TABLET	Resolved	2023-07-20	2024-01-19	199398
TEVA-ROSUVASTATIN	10MG	TABLET	Resolved	2023-07-27	2024-01-19	200290
TEVA-ROSUVASTATIN	10MG	TABLET	Resolved	2024-01-11	2024-02-01	215731
TEVA-ROSUVASTATIN	10MG	TABLET	Actual shortage	2026-01-08	2026-01-22	275481
TEVA-ROSUVASTATIN	20MG	TABLET	Resolved	2019-06-18	2019-11-21	86914
TEVA-ROSUVASTATIN	20MG	TABLET	Resolved	2019-06-18	2019-11-21	86917

Previous
1
…
26
27
28

Showing 271 to 277 of 277

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TEVA-ROSUVASTATIN	20MG	TABLET	Discontinued	2022-03-25	2022-03-26	157434
TEVA-ROSUVASTATIN	20MG	TABLET	Reversed	2025-05-28	2025-06-04	258765
TEVA-ROSUVASTATIN	40MG	TABLET	Discontinued	2022-03-25	2022-03-26	157437

Previous
1
…
3
4
5

Showing 41 to 43 of 43